B. Karki, T. W. Sherpa, R. K. Deo, and P. Thapa, “Clinical response to Rifaximin amongst irritable bowel syndrome (IBS) patients at tertiary level hospital in Nepal”, JPAHS, vol. 11, no. 1, pp. 21–26, Jun. 2024.